Skip to main content

Table 1 Details of the disease stage, chemotherapy treatment and disease outcome of the 23 patients within the study

From: Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer

Patient Stage Received chemotherapy Outcome
1 II None Good
2 II None Good
3 II None Poor
4 II None Good
5 II None Good
6 II None Poor
7 II None Poor
8 II 5FU + Leu Good
9 III None Good
10 III Fol + 5FU + Oxal + Irin Poor
11 III 5FU + Leu Good
12 III 5FU + Leu Good
13 III 5FU + Leu Poor
14 III 5FU + Leu Good
15 III Fol + 5FU + Oxal Good
16 III Fol + 5FU + Oxal Poor
17 III 5FU + Leu Good
18 III Fol + 5FU + Oxal Poor
19 III 5FU + Leu Good
20 III 5FU + Leu Good
21 III 5FU + Leu + Irin + bevacizumab Poor
22 III 5FU + Leu Good
23 III 5FU + Leu Good
  1. 5FU 5-fluorouracil; Fol Fluorouracil; Irin irinotecan; Leu leucovorin; Oxal oxaliplatin; None no chemotherapy received